JP2024527933A - 改良されたｃｒｉｓｐｒ－ｃａｓ技術 - Google Patents

改良されたｃｒｉｓｐｒ－ｃａｓ技術 Download PDF

Info

Publication number
JP2024527933A
JP2024527933A JP2024504805A JP2024504805A JP2024527933A JP 2024527933 A JP2024527933 A JP 2024527933A JP 2024504805 A JP2024504805 A JP 2024504805A JP 2024504805 A JP2024504805 A JP 2024504805A JP 2024527933 A JP2024527933 A JP 2024527933A
Authority
JP
Japan
Prior art keywords
nucleic acid
target nucleic
guide
cas protein
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024504805A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024527933A5 (https=
Inventor
プラディープ ラメシュ，
ウィリアム ジェレミー ブレイク，
ブレンダン ジョン マニング，
Original Assignee
シャーロック バイオサイエンシーズ， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by シャーロック バイオサイエンシーズ， インコーポレイテッド filed Critical シャーロック バイオサイエンシーズ， インコーポレイテッド
Publication of JP2024527933A publication Critical patent/JP2024527933A/ja
Publication of JP2024527933A5 publication Critical patent/JP2024527933A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C12Q1/6823—Release of bound markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C12N9/222—Clustered regularly interspaced short palindromic repeats [CRISPR]-associated [CAS] enzymes
    • C12N9/226—Class 2 CAS enzyme complex, e.g. single CAS protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C12Q1/682—Signal amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2024504805A 2021-07-26 2022-07-26 改良されたｃｒｉｓｐｒ－ｃａｓ技術 Pending JP2024527933A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163225802P 2021-07-26 2021-07-26
US63/225,802 2021-07-26
PCT/US2022/038352 WO2023009526A2 (en) 2021-07-26 2022-07-26 Improved crispr-cas technologies

Publications (2)

Publication Number Publication Date
JP2024527933A true JP2024527933A (ja) 2024-07-26
JP2024527933A5 JP2024527933A5 (https=) 2025-08-04

Family

ID=85088236

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024504805A Pending JP2024527933A (ja) 2021-07-26 2022-07-26 改良されたｃｒｉｓｐｒ－ｃａｓ技術

Country Status (11)

Country Link
US (1) US20250320545A1 (https=)
EP (1) EP4377462A4 (https=)
JP (1) JP2024527933A (https=)
KR (1) KR20240051337A (https=)
CN (1) CN118019857A (https=)
AU (1) AU2022319703A1 (https=)
CA (1) CA3226885A1 (https=)
IL (1) IL310364A (https=)
MX (1) MX2024001267A (https=)
TW (1) TW202321454A (https=)
WO (1) WO2023009526A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20260043073A1 (en) 2022-07-01 2026-02-12 Sherlock Biosciences, Inc. Ambient temperature nucleic acid amplification and detection

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11866697B2 (en) * 2017-05-18 2024-01-09 The Broad Institute, Inc. Systems, methods, and compositions for targeted nucleic acid editing
US20190218544A1 (en) * 2017-10-31 2019-07-18 Takara Bio Usa, Inc. Gene editing, identifying edited cells, and kits for use therein
WO2019178428A1 (en) * 2018-03-14 2019-09-19 Arbor Biotechnologies, Inc. Novel crispr dna and rna targeting enzymes and systems
US12258594B2 (en) * 2018-12-05 2025-03-25 The Broad Institute, Inc. Cas proteins with reduced immunogenicity and methods of screening thereof
AU2021212731A1 (en) * 2020-01-27 2022-08-25 Sherlock Biosciences, Inc. Improved detection assays

Also Published As

Publication number Publication date
AU2022319703A1 (en) 2024-02-29
WO2023009526A2 (en) 2023-02-02
CA3226885A1 (en) 2023-02-02
KR20240051337A (ko) 2024-04-19
EP4377462A4 (en) 2025-07-02
CN118019857A (zh) 2024-05-10
WO2023009526A3 (en) 2023-09-28
US20250320545A1 (en) 2025-10-16
IL310364A (en) 2024-03-01
EP4377462A2 (en) 2024-06-05
MX2024001267A (es) 2024-04-18
TW202321454A (zh) 2023-06-01

Similar Documents

Publication Publication Date Title
Granados-Riveron et al. CRISPR–Cas13 precision transcriptome engineering in cancer
US12065667B2 (en) Modified Cpf1 MRNA, modified guide RNA, and uses thereof
AU2015101418A6 (en) Compositions and methods of nucleic acid-targeting nucleic acids
KR102310441B1 (ko) Rna-염색질 상호작용 분석용 조성물 및 이의 용도
JP5431351B2 (ja) バイサルファイト修飾された核酸を増幅およびコピーするための酵素
WO2024012300A1 (zh) 一种基因编辑的方法和用途
JP7006873B2 (ja) 突然変異細胞遊離遺伝子分離キット及びそれを用いた突然変異細胞遊離遺伝子分離方法
WO2023055893A1 (en) Gene regulation
CN109295054B (zh) 用于靶向病原体基因RNA的gRNA及基于C2c2的病原体基因的检测方法及试剂盒
US20250320545A1 (en) Improved crispr-cas technologies
CN109957568B (zh) 用于靶向HBB RNA的gRNA及基于C2c2的HBB突变检测方法、检测试剂盒
US20250277256A1 (en) Nucleic acid detection and analysis systems
US20230313231A1 (en) Rna and dna base editing via engineered adar
CN109295055B (zh) 基于C2c2的肿瘤相关突变基因的gRNA、检测方法、检测试剂盒
Niu et al. DNA 5-methylcytosine regulates genome-wide formation of G-quadruplex structures
WO2023239609A1 (en) Promoting nutrient absorption through the colon
US12435335B2 (en) Promoting nutrient absorption through the colon
US20250034520A1 (en) Increasing developmental potential of human preimplantation embryos by reducing genetic instability, aneuploidies and chromosomal mosaicism
US20250051773A1 (en) Dnazyme and use thereof
Chong DICER1 mutations: clinical applications, novel associations and functional evaluation
TW202440915A (zh) 報導子優選之附帶切割
EP4352251A2 (en) Compositions and methods for large-scale in vivo genetic screening
Sullivan Understanding the Cellular Consequences of Meier-Gorlin Syndrome
Gramling Genomic Instability-Indicated Mechanisms of Early Carcinogenesis Following Hepatocarcinogen Treatment

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250725

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250725